Confounders for interpreting the benefit of a biomarker-based strategy in early discontinuation of empirical antifungal therapy.
Satoshi YamagaShinichiro OhshimoNobuaki ShimeSaad NseirBoualem SendidAnahita RouzéPublished in: Intensive care medicine (2018)